A Review on the Some Biological Activities of the Hydantoin Derivatives
Hydantoin derivatives are commonly used anticonvulsants. In general, they are effective for partial-onset seizures and tonic-clonic seizures, but not for absence seizures. Phenytoin is the most important drug in this group, and other drugs, ethotoin, and mephenytoin, are also commonly used to treat epilepsy. Prodrugs such as derivatives have been created. Phenytoin is effective in some cases of trigeminal neuralgia and related neuralgia. Phenytoin is also used to treat arrhythmias. Hydantoins or glycolylureas are heterocyclic organic compounds with the formula CH2C(O)NHC(O)NH. It is a colorless solid formed by the reaction of glycolic acid and urea. It is an oxidized derivative of imidazolidine. In a more general sense, hydantoins can refer to groups and classes of compounds that share the same ring structure as their parent. For example, phenytoin (see below) has two phenyl groups substituted at the 5th carbon of the hydantoin molecule. Actual chemotherapy for epilepsy dates back to the 1850s when "inorganic bromides" were introduced. However, it is worth noting that around the 1920s, the therapeutic and beneficial use of 'phenobarbital' usheredin an era of meaningful treatment of epilepsy. Hydantoin ring chemistry is the synthesis of rings by various methods and their applications in the medical field. Previous descriptions of hydantoin-containing compounds have broad pharmacological and biological activities, including anticancer, anti-inflammatory, anti-immune, antimetabolite, antioxidant, antibacterial, CNS-related, anticonvulsant, antitussive, and cytoprotective activities.
Keywords: Hydantoin derivatives, anticonvulsants, partial-onset seizures and tonic-clonic seizures
2. Kalník M, Gabko P, Bella M, Koóš M. The bucherer-bergs multicomponent synthesis of hydantoins-Excellence in simplicity. Vol. 26, Molecules. MDPI AG; 2021. https://doi.org/10.3390/molecules26134024
3. Loser D, Schaefer J, Danker T, Möller C, Brüll M, Suciu I, et al. Human neuronal signaling and communication assays to assess functional neurotoxicity. Arch Toxicol. 2021; 95(1):229-52. https://doi.org/10.1007/s00204-020-02956-3
4. Anil Kumar S, Bhaskar BL. Spectroscopic and Computational approach for the Structure-Property relationship of Hydantoin drug impurity : 1-methyl-5,5-diphenylimidazolidine-2, 4-dione. In: IOP Conference Series: Materials Science and Engineering. IOP Publishing Ltd; 2019. https://doi.org/10.1088/1757-899X/577/1/012180
5. Yu V, Ten A, Baktybayeva L, Sagatbekova I, Praliyev K, Zolotareva D, et al. Synthesis and Biological Evaluation of 1,3,8-Triazaspiro[4.5]decane-2,4-dione Derivatives as Myelostimulators. J Chem. 2018; 2018. https://doi.org/10.1155/2018/7346835
6. Katiyar P, Kumar Verma S, Umar S, Chauhan P, Verma N. Recent advances in the synthesis and medicinal application of hydantoin: a valuable scaffold in medicinal chemistry. Certified Journal │ Verma et al World Journal of Pharmaceutical Research 243 World Journal of Pharmaceutical Research SJIF Impact Factor [Internet]. 2015; 11(1):243-66. Available from: www.wjpr.net
7. Tijsma A, Thibaut HJ, Franco D, Dallmeier K, Neyts J. Hydantoin: The mechanism of its in vitro anti-enterovirus activity revisited. Antiviral Res. 2016 Sep 1; 133:106-9. https://doi.org/10.1016/j.antiviral.2016.07.023
8. Cook AM, Bensalem-Owen MK. Mechanisms of action of antiepileptic drugs. Vol. 8, Therapy. 2011. p. 307-13. https://doi.org/10.2217/thy.11.19
9. Smith CT, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database of Systematic Reviews. 2009.
10. Simas MJ. Biological activity of well definedhydantoin derivatives on efflux pump systems of bacteria and cancer cells. Universidade nova de lisboainstituto de higiene e medicina tropical; 2010.
11. Konnert L, Lamaty F, Martinez J, Colacino E. Recent Advances in the Synthesis of Hydantoins: The State of the Art of a Valuable Scaffold. Vol. 117, Chemical Reviews. American Chemical Society; 2017. p. 13757-809. https://doi.org/10.1021/acs.chemrev.7b00067
12. Mali SN, Pandey A, Bhandare RR, Shaik AB. Identification of hydantoin based Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools. Sci Rep. 2022; 12(1). https://doi.org/10.1038/s41598-022-20325-1
13. CLAUDIA TSCHESCHE. Deltamethrin resistance in salmon lice: Genetic markers and molecular mechanisms. institute of aquaculture, faculty of natural sciences university of stirlingunited kingdom; 2021.
14. Zhao H, Yu R, Qiao H, Liu C. Study on the Formation of Glycine by Hydantoin and Its Kinetics. ACS Omega. 2020; 5(23):13463-72. https://doi.org/10.1021/acsomega.9b03868
15. Eckrich T. Voltage gated Na + channels and spontaneous action potential activity in cochlear hair cells during development. University of Sheffield, Department of Biomedical Science; 2012.
16. Catterall WA. Cellular and Molecular Biology of Voltage-Gated Sodium Channels. Pharmacol Rev [Internet]. 1992; 72(4):22-4. Available from: www.physiology.org/journal/physrev https://doi.org/10.1152/physrev.1992.72.suppl_4.S15
17. Cherneva E, Atanasova M, Šmelcerović Ž, Tomović K, Buyukliev R, Šmelcerović A, et al. 3′-Aminothiocyclohexanespiro-5′-hydantoin and Its Pt(II) Complex-Synthesis, Cytotoxicity and Xanthine Oxidase Inhibitory Activity. Inorganics (Basel). 2022; 10(10). https://doi.org/10.3390/inorganics10100175
18. L. MACHADO. Biological Activity of Twenty-three Hydantoin Derivatives on Intrinsic Efflux Pump System of Salmonella entericaserovarEnteritidis NCTC 13349. International Journal of Pharmaceutical science . 2011; 25(2011):769-72.
19. Dürr R, Vielhauer O, Burton SG, Cowan DA, Puñal A, Brandão PFB, et al. Distribution of hydantoinase activity in bacterial isolates from geographically distinct environmental sources. J MolCatal B Enzym. 2006; 39(1-4):160-5. https://doi.org/10.1016/j.molcatb.2006.01.017
20. Sills GJ, Butler E, Thompson GG, Brodie MJ. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study. IJCRR. 2012; 2(50):1-8.
21. French JA, KannerAM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Approved by the Quality Standards Subcommittee on. Vol. 45, Epilepsia. issue of Neurology; 2004.
22. N James. Nitric Oxide as an Autocrine Regulator of Sodium Currents in Baroreceptor Neurons. Core Journal of medical science. 2008; 20(1):1-11.
23. Biton V, Montouris ; G D, Ritter ; F, Riviello ; J J, Reife ; R, Lim ; P, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. American Academy of Neurology. 1999; 2(20):2-8. https://doi.org/10.1212/WNL.52.7.1330
24. Deshmukh R, Thakur AS, Dewangan D. Mechanism of action of anticonvulsant drugs: a review. Ijpsr [Internet]. 2011; 2(2):225-36. Available from: www.ijpsr.com
25. de Queiroz RB, de Carvalho FL, da Fonsêca DV, Barbosa-Filho JM, Salgado PRR, Paulo LL, et al. Antinociceptive effect of hydantoin 3-phenyl-5-(4-ethylphenyl)-imidazolidine-2,4-dione in mice. Molecules. 2015 Jan 1; 20(1):974-86. https://doi.org/10.3390/molecules20010974
26. Anes J, McCusker MP, Fanning S, Martins M. The ins and outs of RND efflux pumps in Escherichia coli. Vol. 6, Frontiers in Microbiology. Frontiers Media S.A.; 2015. https://doi.org/10.3389/fmicb.2015.00587
27. Leander JD, Rathbun RC, Zimmerman DM. Anticonvulsant effects of phencyclidine-like drugs" relation to N-methyl-o-aspartic acid antagonism. Brain research journal . 1988; 455(20):1-5. https://doi.org/10.1016/0006-8993(88)90839-6
28. Corrêa JD, Queiroz-Junior CM, Costa JE, Teixeira AL, Silva TA. Phenytoin-Induced Gingival Overgrowth: A Review of the Molecular, Immune, and Inflammatory Features. ISRN Dent. 2011 Jul 25; 2011:1-8. https://doi.org/10.5402/2011/497850
29. Porter RJ, Rogawski MA. New Antiepileptic Drugs: From Serendipity to Rational Discovery. Vol. 33, Epilepsia. 1992. https://doi.org/10.1111/j.1528-1157.1992.tb05895.x
30. Davis MP. Drug management of visceral pain: Concepts from basic research. Vol. 2012, Pain Research and Treatment. 2012. https://doi.org/10.1155/2012/265605
31. Rajesh Jogdand K, LiladharKathane L, Kuhite NG, DeoraoPadole C, Amdare MD, Mahapatra DK. Fabricating Hydantoin / Thiohydantoin Hybrids from A Natural Product, Cuminaldehyde: New Players for Anti-Convulsant Therapeutics. Scholars Academic Journal of Pharmacy (SAJP) [Internet]. 2017; 6(7):300-3. Available from: http://saspublisher.com/sajp/300
32. Trišović N, Valentić N, Ušćumlić G. Solvent effects on the structure-property relationship of anticonvulsant hydantoin derivatives: A solvatochromic analysis. Chem Cent J. 2011 Oct 14; 5(1). https://doi.org/10.1186/1752-153X-5-62
33. Cavazzoni A, Alfieri RR, Carmi C, Zuliani V, Galetti M, Fumarola C, et al. Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines. Mol Cancer Ther. 2008 Feb 1; 7(2):361-70. https://doi.org/10.1158/1535-7163.MCT-07-0477
34. Azizmohammadi M, Khoobi M, Ramazani A, Emami S, Zarrin A, Firuzi O, et al. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Eur J Med Chem. 2013 Jan; 59:15-22. https://doi.org/10.1016/j.ejmech.2012.10.044
35. Otrebska-Machaj E, Chevalier J, Handzlik J, Szymanska E, Schabikowski J, Boyer G, et al. Efflux pump blockers in Gram-negative bacteria: The new generation of hydantoin based-modulators to improve antibiotic activity. Front Microbiol. 2016; 7(MAY). https://doi.org/10.3389/fmicb.2016.00622
36. Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: synthesis, characterization and molecular docking studies. MOJ Bioorganic & Organic Chemistry. 2018; 2(2). https://doi.org/10.15406/mojboc.2018.02.00055
37. Abida ., TauquirAlam M, Asif M. Study of Some Hyndantion Derivatives as Anticonvulsant Agents. Progress in Chemical and Biochemical Research. 2020; 3(2):93-104. https://doi.org/10.33945/SAMI/PCBR.2020.2.2
38. Faingold CL, Browning RA. Mechanisms of anticonvulsant drug action I. Drugs primarily used for generalized tonic-clonic and partial epilepsies. European Journal of Eur J Pediatr. Springer-Verlag; 1987; 146. https://doi.org/10.1007/BF00647273
39. Martins A, Spengler G, Rodrigues L, Viveiros M, Ramos J, Martins M, et al. pH modulation of efflux pump activity of multi-drug resistant Escherichia coli: Protection during its passage and eventual colonization of the colon. PLoS One. 2009; 4(8). https://doi.org/10.1371/journal.pone.0006656
40. Kalník M, Gabko P, Bella M, Koóš M. The bucherer-bergs multicomponent synthesis of hydantoins-Excellence in simplicity. Molecules. MDPI AG; 2021; 26. https://doi.org/10.3390/molecules26134024
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).